| Typicality: | 0.501 |
| Saliency: | 0.210 |
| at a later stage | 4 | temporal |
| vaccine → be used in → africa | 7 |
| vaccine → be administered in → africa | 4 |
| vaccine → be tested in → africa | 3 |
| negative | neutral | positive |
| 0.257 | 0.655 | 0.087 |
| Raw frequency | 14 |
| Normalized frequency | 0.210 |
| Modifier score | 1.000 |
| Perplexity | 81.537 |